retatrutide liver Retatrutide, the triple G, Glucagon-GIP-GLP-1 based triagonist produces substantial resolution of fat #NAFLD in PPL with #obesity #ADA2023 @ADA_DiabetesPro @AmDiabetesAssn #NASH trial coming Triple hormone receptor agonist retatrutide
Description
Response Rate Analysis Beyond averages, the proportion of participants achieving clinically significant thresholds demonstrates Retatrutides consistency
I think menopause should be optional
18 612 months: Sustained hormone improvements
The findings reveal a fundamental change in how people eat, spend, and take care of themselves
Stopping medication without intensive lifestyle support typically results in substantial regain
